SEC 13F Intelligence

Boxer Capital, LLC / SG7

Boxer Capital, LLC’s Sage Therapeutics Inc Position

Does Boxer Capital, LLC own Sage Therapeutics Inc (SG7)? Not currently — the last reported position was 1.09M shares worth $23M in Q3 2023; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$23M
Q3 2023
Shares
1.09M
% of Portfolio
+1.20%
Quarters Held
16
position exited

Position History SG7

Reported value by quarter
Q4 ’19: $25MQ4 ’19Q1 ’20: $44MQ2 ’20: $45MQ2 ’20Q3 ’20: $67MQ4 ’20: $95MQ4 ’20Q1 ’21: $82MQ2 ’21: $62MQ2 ’21Q3 ’21: $48MQ4 ’21: $47MQ4 ’21Q1 ’22: $36MQ2 ’22: $35MQ2 ’22Q3 ’22: $43MQ4 ’22: $42MQ4 ’22Q1 ’23: $45,904Q2 ’23: $51,440Q2 ’23Q3 ’23: $23Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20231.09M$23M+1.20%
Q2 20231.09M$51,440+2.39%
Q1 20231.09M$45,904+2.26%
Q4 20221.09M$42M+2.20%
Q3 20221.09M$43M+2.41%
Q2 20221.09M$35M+2.24%
Q1 20221.09M$36M+1.86%
Q4 20211.09M$47M+1.81%
Q3 20211.09M$48M+1.69%
Q2 20211.09M$62M+2.19%
Q1 20211.09M$82M+2.78%
Q4 20201.09M$95M+3.04%
Q3 20201.09M$67M+2.31%
Q2 20201.09M$45M+2.00%
Q1 20201.53M$44M+3.00%
Q4 2019350.0K$25M+1.43%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of SG7.